Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy
- PMID: 12970294
- DOI: 10.1210/jc.2003-030380
Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy
Abstract
Graves' ophthalmopathy (GO) is an autoimmune disorder involving the adipose and connective tissues of the orbit. The study of cytokines present in these tissues may reveal the nature of the cells and immune responses involved in GO pathogenesis. In the current study, we performed relative quantification of the expression of cytokine genes in orbital adipose tissue from patients with GO (n = 6) and normal individuals (n = 2). Real-time RT-PCR was performed using fluorescent probes and primers for cytokines including IL-1 beta, IL-2, IL-4, IL-5, IL-8, IL-10, IFN-gamma, and TNF-alpha. Results showed IL-1 beta to be the gene having the greatest fold expression increase over normal in four of six patients. TNF-alpha was increased in all six GO patients. In addition, IL-8, IL-10, and IFN-gamma were increased in five of six GO patients. We found no evidence of either IL-4 or IL-5 expression in any of the GO or normal samples. The increased expression of the macrophage-derived cytokines IL-1 beta, TNF-alpha, and IL-10 suggests the presence of macrophage activation and ongoing antigen presentation within the orbit in GO. In addition, the overexpression of IFN-gamma, without evidence of IL-4 or IL-5 expression, supports the concept that cell-mediated, rather than humoral, immunity plays the predominant role in pathogenesis of this disorder.
Similar articles
-
Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue.J Clin Endocrinol Metab. 1994 May;78(5):1070-4. doi: 10.1210/jcem.78.5.8175962. J Clin Endocrinol Metab. 1994. PMID: 8175962
-
Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.Thyroid. 2003 Sep;13(9):845-50. doi: 10.1089/105072503322401032. Thyroid. 2003. PMID: 14588098
-
TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.Clin Endocrinol (Oxf). 2003 Mar;58(3):280-7. doi: 10.1046/j.1365-2265.2003.01708.x. Clin Endocrinol (Oxf). 2003. PMID: 12608932
-
Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.Thyroid. 2002 Mar;12(3):193-5. doi: 10.1089/105072502753600124. Thyroid. 2002. PMID: 11952038 Review.
-
Thyroid-associated eye disease.Strabismus. 2000 Jun;8(2):101-11. Strabismus. 2000. PMID: 10980691 Review.
Cited by
-
Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.Thyroid. 2008 Sep;18(9):953-8. doi: 10.1089/thy.2007.0405. Thyroid. 2008. PMID: 18713026 Free PMC article. Review.
-
Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.Thyroid. 2008 Dec;18(12):1291-6. doi: 10.1089/thy.2008.0255. Thyroid. 2008. PMID: 18976167 Free PMC article.
-
Current and Emerging Treatment Strategies for Graves' Orbitopathy.Drugs. 2019 Feb;79(2):109-124. doi: 10.1007/s40265-018-1045-9. Drugs. 2019. PMID: 30659423 Review.
-
Blood-aqueous barrier integrity in patients with Graves' ophthalmopathy (GO), before and after rehabilitative surgery.Eye (Lond). 2015 Apr;29(4):542-51. doi: 10.1038/eye.2014.337. Epub 2015 Feb 13. Eye (Lond). 2015. PMID: 25679415 Free PMC article.
-
Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.PLoS One. 2020 Aug 6;15(8):e0237015. doi: 10.1371/journal.pone.0237015. eCollection 2020. PLoS One. 2020. PMID: 32760098 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources